Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-003896
Filing Date
2012-01-26
Accepted
2012-01-26 12:06:35
Documents
1
Period of Report
2012-01-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 - BOOTH rrd331566.html 4  
1 FORM 4 - BOOTH rrd331566.xml 4 4271
  Complete submission text file 0001181431-12-003896.txt   5650
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Issuer) CIK: 0001382911 (see all company filings)

EIN.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3344 N. TORREY PINES COURT, SUITE 200 LA JOLLA CA 92037
Business Address
Booth Mark D (Reporting) CIK: 0001470885 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33415 | Film No.: 12546562